{"database": "lobbying", "table": "lobbying_activities", "rows": [[2307555, "295cd029-5684-4e30-b130-f32999bf622f", "Q2", "KOUNTOUPES DENHAM CARR & REID, LLC", 320918, "CVS HEALTH", 2019, "second_quarter", "PHA", "General education about the pharmacy benefit manager/pharmacy industry, including S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU)Act.  Issues related to Risk Evaluation and Mitigation Strategies (REMS) program, including S.340 and H. R. 965, The CREATES Act.  S. 1895, Lower Health Case Costs Act; S.1227, The Prescription Pricing for the People Act of 2019.", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", 60000, null, 0, 0, "2019-07-17T14:21:21.340000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2307555"], "units": {}, "query_ms": 0.38475997280329466, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}